These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 24063277)

  • 1. The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.
    Brents LK; Prather PL
    Drug Metab Rev; 2014 Feb; 46(1):72-85. PubMed ID: 24063277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?
    Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL
    Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential drug-drug interactions of the synthetic Cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy.
    Brents LK; Zimmerman SM; Saffell AR; Prather PL; Fantegrossi WE
    J Pharmacol Exp Ther; 2013 Sep; 346(3):350-61. PubMed ID: 23801678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic Cannabinoids.
    Mills B; Yepes A; Nugent K
    Am J Med Sci; 2015 Jul; 350(1):59-62. PubMed ID: 26132518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of classical cannabinoids and the synthetic cannabinoid JWH-018.
    Su MK; Seely KA; Moran JH; Hoffman RS
    Clin Pharmacol Ther; 2015 Jun; 97(6):562-4. PubMed ID: 25788107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids.
    Sholler DJ; Huestis MA; Amendolara B; Vandrey R; Cooper ZD
    Pharmacol Biochem Behav; 2020 Dec; 199():173059. PubMed ID: 33086126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a high-performance liquid chromatography-tandem mass spectrometry method for the identification and quantification of CP-47,497, CP-47,497-C8 and JWH-250 in mouse brain.
    Samano KL; Poklis JL; Lichtman AH; Poklis A
    J Anal Toxicol; 2014; 38(6):307-14. PubMed ID: 24816398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.
    Brents LK; Gallus-Zawada A; Radominska-Pandya A; Vasiljevik T; Prisinzano TE; Fantegrossi WE; Moran JH; Prather PL
    Biochem Pharmacol; 2012 Apr; 83(7):952-61. PubMed ID: 22266354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spicing things up: synthetic cannabinoids.
    Spaderna M; Addy PH; D'Souza DC
    Psychopharmacology (Berl); 2013 Aug; 228(4):525-40. PubMed ID: 23836028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
    Every-Palmer S
    Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice.
    Wilson CD; Tai S; Ewing L; Crane J; Lockhart T; Fujiwara R; Radominska-Pandya A; Fantegrossi WE
    J Pharmacol Exp Ther; 2019 Feb; 368(2):146-156. PubMed ID: 30420360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
    Dresen S; Ferreirós N; Pütz M; Westphal F; Zimmermann R; Auwärter V
    J Mass Spectrom; 2010 Oct; 45(10):1186-94. PubMed ID: 20857386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Pot: Not Your Grandfather's Marijuana.
    Ford BM; Tai S; Fantegrossi WE; Prather PL
    Trends Pharmacol Sci; 2017 Mar; 38(3):257-276. PubMed ID: 28162792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events.
    Davidson C; Opacka-Juffry J; Arevalo-Martin A; Garcia-Ovejero D; Molina-Holgado E; Molina-Holgado F
    Adv Pharmacol; 2017; 80():135-168. PubMed ID: 28826533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.
    Seely KA; Lapoint J; Moran JH; Fattore L
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):234-43. PubMed ID: 22561602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey study to characterize use of Spice products (synthetic cannabinoids).
    Vandrey R; Dunn KE; Fry JA; Girling ER
    Drug Alcohol Depend; 2012 Jan; 120(1-3):238-41. PubMed ID: 21835562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?
    Seely KA; Prather PL; James LP; Moran JH
    Mol Interv; 2011 Feb; 11(1):36-51. PubMed ID: 21441120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered metabolism of synthetic cannabinoid JWH-018 by human cytochrome P450 2C9 and variants.
    Patton AL; Seely KA; Yarbrough AL; Fantegrossi W; James LP; McCain KR; Fujiwara R; Prather PL; Moran JH; Radominska-Pandya A
    Biochem Biophys Res Commun; 2018 Apr; 498(3):597-602. PubMed ID: 29522717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Web searches to track interest in synthetic cannabinoids (a/k/a 'herbal incense').
    Curtis B; Alanis-Hirsch K; Kaynak Ö; Cacciola J; Meyers K; McLellan AT
    Drug Alcohol Rev; 2015 Jan; 34(1):105-8. PubMed ID: 25196534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Synthetic Cannabinoids Phenomenon.
    Karila L; Benyamina A; Blecha L; Cottencin O; Billieux J
    Curr Pharm Des; 2016; 22(42):6420-6425. PubMed ID: 27655416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.